These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11733734)
1. Gene-mediated inhibition of the b-adrenergic receptor kinase: a new therapeutic strategy for heart failure. Tevaearai HT; Eckhart AD; Koch WJ Minerva Cardioangiol; 2001 Dec; 49(6):389-94. PubMed ID: 11733734 [TBL] [Abstract][Full Text] [Related]
2. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts. Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637 [TBL] [Abstract][Full Text] [Related]
3. Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex. Perrino C; Naga Prasad SV; Schroder JN; Hata JA; Milano C; Rockman HA Circulation; 2005 May; 111(20):2579-87. PubMed ID: 15897344 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy. Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854 [TBL] [Abstract][Full Text] [Related]
5. Right ventricular beneficial effects of beta adrenergic receptor kinase inhibitor (betaARKct) gene transfer in a rat model of severe pressure overload. Molina EJ; Gupta D; Palma J; Gaughan JP; Macha M Biomed Pharmacother; 2009 Jun; 63(5):331-6. PubMed ID: 18801641 [TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression. Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620 [TBL] [Abstract][Full Text] [Related]
7. [Gene therapy and benefits in modulating of system beta-adrenergic in cardiac insufficiency]. Tevaearai HT; Walton GB; Koch WJ Rev Med Suisse Romande; 2002 Mar; 122(3):149-53. PubMed ID: 12014253 [TBL] [Abstract][Full Text] [Related]
8. Acute ischemic cardiac dysfunction is attenuated via gene transfer of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARK1). Tevaearai HT; Walton GB; Keys JR; Koch WJ; Eckhart AD J Gene Med; 2005 Sep; 7(9):1172-7. PubMed ID: 15880449 [TBL] [Abstract][Full Text] [Related]
9. Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization. Hata JA; Williams ML; Koch WJ J Mol Cell Cardiol; 2004 Jul; 37(1):11-21. PubMed ID: 15242731 [TBL] [Abstract][Full Text] [Related]
10. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure. Koch WJ Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162 [TBL] [Abstract][Full Text] [Related]
11. Effects of two Gbetagamma-binding proteins--N-terminally truncated phosducin and beta-adrenergic receptor kinase C terminus (betaARKct)--in heart failure. Li Z; Laugwitz KL; Pinkernell K; Pragst I; Baumgartner C; Hoffmann E; Rosport K; Münch G; Moretti A; Humrich J; Lohse MJ; Ungerer M Gene Ther; 2003 Aug; 10(16):1354-61. PubMed ID: 12883532 [TBL] [Abstract][Full Text] [Related]
12. [Gene transfer of a beta-adrenergic receptor kinase inhibitor up-regulates the level of beta2-adrenergic receptor and cyclic adenosine monophosphate in the asthmatic murine lung]. Huang M; Wu Y; Yao X; Cha WJ; Yin KS Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):756-9. PubMed ID: 15634388 [TBL] [Abstract][Full Text] [Related]
13. Gene transfer of beta-adrenergic signaling components for heart failure. Koch WJ J Card Fail; 2002 Dec; 8(6 Suppl):S526-31. PubMed ID: 12555169 [TBL] [Abstract][Full Text] [Related]
14. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function. Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103 [TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of phosphoinositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure. Perrino C; Rockman HA; Chiariello M Vascul Pharmacol; 2006 Aug; 45(2):77-85. PubMed ID: 16807128 [TBL] [Abstract][Full Text] [Related]
18. Molecular restoration of beta-adrenergic receptor signaling improves contractile function of failing hearts. Tevaearai HT; Koch WJ Trends Cardiovasc Med; 2004 Aug; 14(6):252-6. PubMed ID: 15451518 [TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha. Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614 [TBL] [Abstract][Full Text] [Related]